WO2008006082A3 - Energy enhancing formulation - Google Patents

Energy enhancing formulation Download PDF

Info

Publication number
WO2008006082A3
WO2008006082A3 PCT/US2007/072982 US2007072982W WO2008006082A3 WO 2008006082 A3 WO2008006082 A3 WO 2008006082A3 US 2007072982 W US2007072982 W US 2007072982W WO 2008006082 A3 WO2008006082 A3 WO 2008006082A3
Authority
WO
WIPO (PCT)
Prior art keywords
formulation
energy enhancing
enhancing formulation
mulungu
theanine
Prior art date
Application number
PCT/US2007/072982
Other languages
French (fr)
Other versions
WO2008006082A2 (en
Inventor
Jon Barron
Original Assignee
Jon Barron
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Jon Barron filed Critical Jon Barron
Publication of WO2008006082A2 publication Critical patent/WO2008006082A2/en
Publication of WO2008006082A3 publication Critical patent/WO2008006082A3/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/82—Theaceae (Tea family), e.g. camellia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/80—Scrophulariaceae (Figwort family)

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • Medical Informatics (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)

Abstract

An herbal formulation comprising mulungu, Bacopa monniera, green tea extract, L-theanine and, optionally, stevia is provided. The formulation, in preferred embodiments, energizes both the mind and body, stimulates the pleasure centers in the brain and body and acts as an appetite suppressant.
PCT/US2007/072982 2006-07-06 2007-07-06 Energy enhancing formulation WO2008006082A2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US81884606P 2006-07-06 2006-07-06
US60/818,846 2006-07-06

Publications (2)

Publication Number Publication Date
WO2008006082A2 WO2008006082A2 (en) 2008-01-10
WO2008006082A3 true WO2008006082A3 (en) 2008-02-28

Family

ID=38895503

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2007/072982 WO2008006082A2 (en) 2006-07-06 2007-07-06 Energy enhancing formulation

Country Status (1)

Country Link
WO (1) WO2008006082A2 (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2255726A1 (en) * 2009-05-26 2010-12-01 Sanofi-Aventis Spectral profile of SWS enhancing drugs
US20130165398A1 (en) 2010-03-29 2013-06-27 Paul Hochegger Concentration-enhancing drink
US20130177690A1 (en) * 2010-10-20 2013-07-11 Yongquan Xue Taste Modifying Composition
EP2574339A1 (en) 2011-09-27 2013-04-03 Johannes Huber Pharmaceutical preparation for treating NADH-related illnesses
WO2015130995A1 (en) * 2014-02-28 2015-09-03 Tripp Matthew L Phosphodiesterase inhibiting phytochemical compositions
WO2017200391A1 (en) * 2016-05-17 2017-11-23 Alphagen Nz Limited Compositions comprising l-theanine, proanthocyanidin/s and a catechin and uses thereof

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5736575A (en) * 1995-10-03 1998-04-07 Ito En Ltd. Excitement accelerating agent

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5736575A (en) * 1995-10-03 1998-04-07 Ito En Ltd. Excitement accelerating agent

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
"the barron report", vol. 13, no. 2, 2004, pages 1 - 4, Retrieved from the Internet <URL:http://www.jonbarron.org/barron_reports/2-1-2004.php> *

Also Published As

Publication number Publication date
WO2008006082A2 (en) 2008-01-10

Similar Documents

Publication Publication Date Title
TWI350286B (en) Alkylpiperazine- and alkylhomopiperazine-carboxylate derivatives, their preparation and their application in therapy
IL180284A0 (en) 2-carbamide-4-phenylthiazole derivatives, preparation thereof and therapeutic use thereof
HK1150731A1 (en) The extract, tea drink and method of producing the same
HK1105161A1 (en) Concentrated coffee extract and process for producing the same
ZA200709266B (en) Human GLP-1 mimetibodies, compositions, methods and uses
ZA200703876B (en) 2-amido -4-phenylthiazole derivatives, the preparation and therapeutic use thereof
IL180770A0 (en) Oxopiperidine derivatives, preparation and therapeutic use thereof
IL180682A0 (en) N-hydroxamide derivatives, their preparation and use
TWI350287B (en) Acylaminothiazole derivatives, their preparation and their therapeutic application
WO2008006082A3 (en) Energy enhancing formulation
IL196788A0 (en) New eucalyptus extract, method of preparation and therapeutic uses thereof
EP1978983A4 (en) Extract of dioscorea sp. and the medical uses thereof
SI1773829T1 (en) Amino-tropane derivatives, preparation thereof and therapeutic use thereof
IL190519A0 (en) 6-heteroarylpyridoindolone derivatives, their preparation and therapeutic use thereof
WO2009151300A3 (en) Extract of coptidis rhizoma and use thereof in treating respiratory disease
EP2083011A4 (en) Pyrroline derivatives against cell releasing tumor necrosis factor, preparation methods and uses thereof
IL198481A0 (en) Pyrrole derivatives, preparation use of the same in therapy
IL180867A0 (en) Pyrrole derivatives, their preparation and their therapeutic use
IL195096A0 (en) Aqueous tobacco leaf extract, uses thereof in the treatment of dependence
HK1139671A1 (en) Azabicycloalkane derivatives, preparation thereof and use thereof in therapy
WO2010129788A3 (en) Uses of cationic hydroxythylcellulose in oral ingestion forms, and prevention and treatment of metabolic disorders
TWI340642B (en) Acylaminothiazole derivatives, preparation and therapeutic application thereof
IL191892A0 (en) 2-carbamide-4-phenylthiazole derivatives, preparation thereof and therapeutic use thereof
IL180484A0 (en) 4-arylmorpholin-3-one derivatives, preparation and therapeutic use thereof
ZA200608999B (en) Human GLP-1 mimetibodies, compositions, methods and uses

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 07812691

Country of ref document: EP

Kind code of ref document: A2

NENP Non-entry into the national phase

Ref country code: DE

NENP Non-entry into the national phase

Ref country code: RU

122 Ep: pct application non-entry in european phase

Ref document number: 07812691

Country of ref document: EP

Kind code of ref document: A2